Cargando…

Deprescribing Strategies: A Prospective Study on Proton Pump Inhibitors

Proton pump inhibitors (PPIs) are among the most controversially prescribed drugs in polypharmacy. This observational prospective study assessed the PPI prescriptive trend during hospitalization before and after implementation of a prescribing/deprescribing algorithm in a real-life hospital setting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvini, Giulia, Baiardi, Giammarco, Mattioli, Francesca, Milano, Giulia, Calautti, Francesca, Zunino, Alessia, Fraguglia, Carla Elda, Caccavale, Fabio, Lantieri, Francesca, Antonucci, Giancarlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140867/ https://www.ncbi.nlm.nih.gov/pubmed/37109364 http://dx.doi.org/10.3390/jcm12083029

Ejemplares similares

Prescriptive Appropriateness: Inhospital Adherence to Proton Pump Inhibitors Deprescription Flow Chart
por: Baiardi, Giammarco, et al.
Publicado: (2023)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Problems Associated with Deprescribing of Proton Pump Inhibitors
por: Helgadottir, Holmfridur, et al.
Publicado: (2019)

Deprescribing in older people: helpful tools and proton pump inhibitors
Publicado: (2020)

Peer-Led Education Expedites Deprescribing Proton Pump Inhibitors for Appropriate Veterans
por: Bowman, Mary H.
Publicado: (2020)

Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients
por: Thompson, Wade, et al.
Publicado: (2020)

Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits
por: Stella, Manuela, et al.
Publicado: (2023)

Development and Validation of a Novel LC-MS/MS Method for a TDM-Guided Personalization of HSCT Conditioning with High-Dose Busulfan in Children
por: Cafaro, Alessia, et al.
Publicado: (2023)

Deprescribing Statins and Proton Pump Inhibitors in Nursing Home Residents; a Pragmatic Exploratory Study
por: Visser, Anne G. R., et al.
Publicado: (2021)

Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans
por: Bhardwaj, Sonia, et al.
Publicado: (2022)

The Clinical Efficacy of Multidose Oritavancin: A Systematic Review
por: Baiardi, Giammarco, et al.
Publicado: (2023)

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study
por: Aubert, Carole E., et al.
Publicado: (2023)

Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan
por: Milano, Giulia, et al.
Publicado: (2017)

Who has the guts to deprescribe proton pump inhibitors? A pharmacist‐led intervention in a long‐term care facility setting
por: Tandun, Rachel, et al.
Publicado: (2019)

Evaluation of physicians’ knowledge of deprescribing, deprescribing tools and assessment of factors affecting deprescribing process
por: Akande-Sholabi, Wuraola, et al.
Publicado: (2023)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
por: Pigliasco, Federica, et al.
Publicado: (2023)

Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
por: Bruno, Giovanni, et al.
Publicado: (2019)

Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports
por: Milano, Giulia, et al.
Publicado: (2014)

Co-Occurring Psychiatric and Substance Use Disorders: Clinical Survey Among a Rural Cohort of Italian Patients
por: Milano, Giulia, et al.
Publicado: (2019)

Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial
por: Nguyen-Soenen, Jérôme, et al.
Publicado: (2022)

Deprescribing: Practical Ways to Support Person-Centred, Evidence-Based Deprescribing
por: Le Bosquet, Katherine, et al.
Publicado: (2019)

Data Fusion Approach to Simultaneously Evaluate the Degradation Process Caused by Ozone and Humidity on Modern Paint Materials
por: Pagnin, Laura, et al.
Publicado: (2022)

Long-Term Neuroradiological and Clinical Evaluation of NBIA Patients Treated with a Deferiprone Based Iron-Chelation Therapy
por: Romano, Nicola, et al.
Publicado: (2022)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

DEPRESCRIBING IN ASSISTED LIVING
por: Zarowitz, Barbara, et al.
Publicado: (2022)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing
por: Farrell, Barbara, et al.
Publicado: (2016)

Impact of Dual Antiplatelet Therapy with Proton Pump Inhibitors on the Outcome of Patients with Acute Coronary Syndrome Undergoing Drug-Eluting Stent Implantation
por: Macaione, Francesca, et al.
Publicado: (2012)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist‐led deprescribing in care homes
por: Birt, Linda, et al.
Publicado: (2022)

Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients Still Need to Be Prompted: A Systematic Review
por: Rosamilia, Francesca, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

A young man with persistent dyspepsia: the unexpected virtue of proton-pump inhibitors
por: Paolo, Fraticelli, et al.
Publicado: (2018)

OSM/OSMR and Interleukin 6 Family Cytokines in Physiological and Pathological Condition
por: Lantieri, Francesca, et al.
Publicado: (2022)

Editorial: Elucidation of the causes of human disease by multi-omics integration
por: Rusmini, Marta, et al.
Publicado: (2023)

Deprescribing in Palliative Cancer Care
por: Hedman, Christel, et al.
Publicado: (2022)

Symposium Abstract Deprescribing in Psychiatry
por: Mudgal, Varchasvi, et al.
Publicado: (2022)

Hyperacidification of Citrus fruits by a vacuolar proton-pumping P-ATPase complex
por: Strazzer, Pamela, et al.
Publicado: (2019)

Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing
por: Kaas Oldenburg, Lykke I., et al.
Publicado: (2022)

Deprescribing—A Few Steps Further
por: Sadowski, Cheryl A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1vmbsv0a1jism5emj08bhh9s3p